RBC transfusion for brain bleed patients with intracranial hemorrhage
Official title: RBc transfusion Characteristics in IntraCranial Hemorrhage (RBC-ICH)
Funded at Columbia University Health Sciences · NIH-11445366 · Data updated 2026-11-12
A small, early-stage study will look at whether providing specific red blood cell transfusions helps people who have an intracranial hemorrhage recover better.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | August 1, 2026 |
| Project end | July 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $246,750 |
| NIH project number | 1R21HL189042-01 |
| Project ID | NIH-11445366 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults with intracranial hemorrhage who have anemia or are at risk of anemia and could potentially receive RBC transfusions.
✕Less likely to help
Patients who do not have anemia or whose condition precludes transfusion may not benefit.
What this research studies
This project focuses on people who have a serious brain bleed and may be anemic. It explores how different red blood cell transfusion strategies could affect brain oxygen delivery and recovery after hemorrhage. The study will examine characteristics of transfused cells and donor factors to see if these influence outcomes. By understanding transfusion effects in ICH, the research could inform more personalized treatment for brain-injury patients.
Why it matters
Potential benefit: If successful, the findings could guide more effective transfusion practices to improve brain recovery after intracranial hemorrhage.
How similar studies have gone: Early data suggest transfusions may help some ICH patients, but results vary across studies and settings.
Where this research is happening
-
Columbia University Health Sciences
New York, United States Active
Researchers
- Principal investigator: Roh, David — Columbia University Health Sciences
- Study coordinator: Roh, David
Related research
Other NIH-funded projects on the same topics.
-
Wearable tech to track blood loss during childbirth
A wearable device monitors cardiovascular signals to detect postpartum hemorrhage early so clinicians can act quickly to protect mothers.
-
SATURN MRI ancillary study: statins after intracerebral hemorrhage and brain MRI markers
This study looks at what happens to brain MRI markers and health outcomes when people with a specific type of brain bleed continue or stop taking statins.
-
Statin use after brain bleed MRI study in ICH patients (SATURN MRI) Ancillary Study
This project tests whether continuing or stopping statin therapy after an intracerebral hemorrhage affects brain changes seen on MRI and related health outcomes in people with lobar ICH.
-
Statin use after brain bleed: SATURN MRI ancillary study
This project tests whether continuing statin medicines after a brain bleed (lobar intracerebral hemorrhage) affects new brain blood vessel findings and long-term health.
-
Maternal Postpartum Monitoring with a Wearable Sensor (MOMS)
A wearable system called MOMS will continuously monitor multiple physiological signals in pregnant people to detect postpartum hemorrhage earlier than standard vital signs.
-
Anticoagulation in ICH Survivors with Atrial Fibrillation and Small Vessel Disease
This project looks at how to safely use blood-thinning medicines in people who survived a brain bleed and also have atrial fibrillation and small vessel disease.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.